Navidea Biopharmaceuticals, Inc. (NAVBQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 21, 2026
NAVBQ Market Cap
NAVBQ has a market cap or net worth of $10 thousand as of October 23, 2026. It is the 51,845th most valuable company in the world and the 7,807th biggest in the United States.
Market Cap
10.00K
Enterprise Value
n/a
Revenue
610.00
Global Rank
Country Rank
#7,807 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 10, 1992, NAVBQ's market cap has decreased from 4.93M to 10.00K, a decrease of -99.80%. That is a compound annual growth rate of -16.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 10.00K | 9,899.00% |
| Dec 31, 2025 | 100.00 | -99.00% |
| Dec 31, 2024 | 10.00K | -99.82% |
| Dec 29, 2023 | 5.52M | -18.56% |
| Dec 30, 2022 | 6.78M | -77.52% |
| Dec 31, 2021 | 30.15M | -47.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Path Holdings | 16.17K |
| Statera Biopharma | 14.52K |
| Vaxxinity | 12.68K |
| ObsEva | 11.72K |
| Syros Pharmaceuticals | 10.73K |
| GeneLink | 10.60K |
| Carisma Therapeutics | 8.37K |
| ZyVersa Therapeutics | 8.10K |